| Organ Transplantation Techniques and Outcomes | Lifetime | 172 | CN 4 | 99.34 |
| Ferroptosis and cancer prognosis | Lifetime | 150 | CN 63 | 97.93 |
| Liver Disease Diagnosis and Treatment | Lifetime | 770 | CN 31 | 99.05 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 285 | CN 27 | 98.96 |
| Cancer-related molecular mechanisms research | Lifetime | 587 | CN 258 | 98.27 |
| Liver Disease and Transplantation | Lifetime | 370 | CN 9 | 98.99 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 364 | CN 29 | 98.46 |
| Hepatitis B Virus Studies | Lifetime | 617 | CN 34 | 98.41 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 837 | CN 23 | 98.22 |
| Liver physiology and pathology | Lifetime | 261 | CN 15 | 97.74 |
| Cancer Mechanisms and Therapy | Lifetime | 305 | CN 42 | 96.83 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 405 | CN 20 | 92.63 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 668 | CN 124 | 90.78 |
| Organ Transplantation Techniques and Outcomes | 2021-2025 | 84 | CN 2 | 97.98 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 174 | CN 33 | 97.82 |
| RNA modifications and cancer | 2021-2025 | 845 | CN 581 | 94.15 |
| Liver Disease and Transplantation | 2021-2025 | 415 | CN 20 | 95.91 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 310 | CN 1 | 94.29 |
| Ferroptosis and cancer prognosis | 2021-2025 | 620 | CN 525 | 92.51 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 112 | CN 17 | 87.49 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 656 | CN 147 | 90.84 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 880 | CN 390 | 86.94 |
| Cancer Cells and Metastasis | 2021-2025 | 706 | CN 141 | 86.48 |
| Liver physiology and pathology | 2021-2025 | 199 | CN 85 | 86.54 |
| Transplantation: Methods and Outcomes | 2021-2025 | 604 | CN 11 | 89.88 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 694 | CN 177 | 75.77 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 968 | CN 135 | 78.56 |
| Cancer Mechanisms and Therapy | 2021-2025 | 781 | CN 347 | 74.37 |
| Phagocytosis and Immune Regulation | 2021-2025 | 735 | CN 308 | 69.17 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 601 | CN 92 | 43.03 |
